Streetbeat News

Earnings

RPM

RPM International Inc (NYSE:RPM) has received mixed analyst ratings over the past quarter, with a range of opinions from bullish to bearish. The average 12-month price target is $125.62, with a high of $140.00 and a low of $110.00. Recent analyst actions include both raises and lowers in price targets, reflecting varied expectations. Despite revenue challenges, RPM Intl shows strong profitability and financial health with impressive net margins, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

August 27, 2024 | 4:01 pm

REGN

The article provides an in-depth analysis of Regeneron Pharmaceuticals (NASDAQ:REGN) compared to its peers in the Biotechnology industry. It highlights Regeneron's potential undervaluation based on its low P/E, P/B, and P/S ratios, despite a lower ROE. The company shows strong operational performance with high EBITDA and gross profit but faces challenges in revenue growth.

Portfolio Pulse from Benzinga Insights

August 27, 2024 | 3:00 pm

JWN

Nordstrom Inc (NYSE:JWN) shares are down 2.49% ahead of its Q2 earnings report, expected to show EPS of 71 cents on $3.896 billion revenue. Despite a Q1 sales beat, profitability was below expectations. Nordstrom pays a 3.96% dividend and has a 52-week high of $24.03.

Portfolio Pulse from Henry Khederian

August 27, 2024 | 2:58 pm

BOX

Box, Inc. (NYSE:BOX) is set to release its Q2 earnings on Aug. 27, with expectations of 40 cents per share and $269.18 million in revenue. Recent analyst ratings show mixed sentiments, with price targets ranging from $30 to $32. Box recently appointed Tricia Gellman as CMO.

Portfolio Pulse from Avi Kapoor

August 27, 2024 | 2:50 pm

LLY

NVDA

The article highlights key market events, including record high house prices in June, Eli Lilly's launch of Zepbound single-dose vials, and NVIDIA's upcoming earnings report. These developments could impact related stocks and ETFs.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 2:41 pm

CRM

Salesforce Inc (NYSE:CRM) is set to report its Q2 earnings, with Wall Street expecting $2.36 EPS and $9.2 billion in revenues. The stock shows a strong bullish trend, trading above key moving averages, though slightly below the 200-day average. Analysts maintain a 'Buy' rating with a price target of $295.19, indicating a potential 15% upside.

Portfolio Pulse from Surbhi Jain

August 27, 2024 | 2:40 pm

ENR

HAIN

SLNO

Hain Celestial reported better-than-expected Q4 earnings, leading to a 34.2% increase in its stock price. Other stocks like Soleno Therapeutics and Energizer Holdings also saw gains due to positive news and analyst upgrades.

Portfolio Pulse from Avi Kapoor

August 27, 2024 | 2:38 pm

SCSC

ScanSource, Inc. reported a significant decline in Q4 revenues and earnings, missing analyst expectations. Despite a challenging demand environment, the company improved its gross margin due to Intelisys's contribution. The stock fell following the earnings report, and an analyst downgraded its rating.

Portfolio Pulse from Anusuya Lahiri

August 27, 2024 | 2:28 pm

CYCN

Cyclerion Therapeutics reported a significant improvement in its Q2 earnings per share, with losses narrowing to $(0.53) from $(1.83) year-over-year, marking a 71.04% increase.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:58 pm

BABA

PDD

PDD Holdings Inc. (NASDAQ:PDD) shares fell nearly 30% after announcing potential short-term profit sacrifices to stay competitive. Despite strong revenue growth, market concerns arose due to a slowdown in growth rate and warnings of future challenges. The company plans to invest in supply chain efficiency and merchant support, impacting future profits.

Portfolio Pulse from The Bamboo Works

August 27, 2024 | 1:57 pm